Lucid Diagnostics (LUCD) Return on Sales Growth (1y) (2022 - 2026)
Lucid Diagnostics (LUCD) Return on Sales Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | 0.00 |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 0.00 |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn | 0.00 |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 0.00 |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn | 0.00 |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn | 0.00 |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 0.00 |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn | 0.00 |
| 10 | Lucid Diagnostics | 130.54 Mn | 102.67 Mn | -325,000.00 | 22.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.00 |
| Dec 31, 2025 | -1.00 |
| Sep 30, 2025 | 2.00 |
| Jun 30, 2025 | 8.00 |
| Mar 31, 2025 | -22.00 |
| Dec 31, 2024 | 1.00 |
| Sep 30, 2024 | 8.00 |
| Jun 30, 2024 | 60.00 |
| Mar 31, 2024 | 26.00 |
| Dec 31, 2023 | 123.00 |
| Sep 30, 2023 | 171.00 |
| Jun 30, 2023 | -6.00 |
| Mar 31, 2023 | 28.00 |
| Dec 31, 2022 | -96.00 |
| Sep 30, 2022 | -154.00 |